rs2855430

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_080680.3(COL11A2):​c.2681C>T​(p.Pro894Leu) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.131 in 1,611,686 control chromosomes in the GnomAD database, including 14,943 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P894R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.10 ( 1012 hom., cov: 27)
Exomes 𝑓: 0.13 ( 13931 hom. )

Consequence

COL11A2
NM_080680.3 missense, splice_region

Scores

4
3
9
Splicing: ADA: 0.9241
1
1

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 9.76

Publications

57 publications found
Variant links:
Genes affected
COL11A2 (HGNC:2187): (collagen type XI alpha 2 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. It is located on chromosome 6 very close to but separate from the gene for retinoid X receptor beta. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Proteolytic processing of this type XI chain produces PARP, a proline/arginine-rich protein that is an amino terminal domain. Mutations in this gene are associated with type III Stickler syndrome, otospondylomegaepiphyseal dysplasia (OSMED syndrome), Weissenbacher-Zweymuller syndrome, autosomal dominant non-syndromic sensorineural type 13 deafness (DFNA13), and autosomal recessive non-syndromic sensorineural type 53 deafness (DFNB53). Alternative splicing results in multiple transcript variants. A related pseudogene is located nearby on chromosome 6. [provided by RefSeq, Jul 2009]
COL11A2 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 13
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • nonsyndromic genetic hearing loss
    Inheritance: AD, AR Classification: DEFINITIVE, MODERATE Submitted by: ClinGen
  • otospondylomegaepiphyseal dysplasia, autosomal dominant
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • autosomal recessive nonsyndromic hearing loss 53
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • otospondylomegaepiphyseal dysplasia
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • otospondylomegaepiphyseal dysplasia, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • fibrochondrogenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0038810372).
BP6
Variant 6-33173503-G-A is Benign according to our data. Variant chr6-33173503-G-A is described in ClinVar as Benign. ClinVar VariationId is 46561.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.172 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL11A2NM_080680.3 linkc.2681C>T p.Pro894Leu missense_variant, splice_region_variant Exon 36 of 66 ENST00000341947.7 NP_542411.2 P13942A0A0C4DFS1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL11A2ENST00000341947.7 linkc.2681C>T p.Pro894Leu missense_variant, splice_region_variant Exon 36 of 66 5 NM_080680.3 ENSP00000339915.2 A0A0C4DFS1
COL11A2ENST00000374708.8 linkc.2423C>T p.Pro808Leu missense_variant, splice_region_variant Exon 34 of 64 5 ENSP00000363840.4 Q4VXY6
COL11A2ENST00000361917.6 linkc.1253C>T p.Pro418Leu missense_variant, splice_region_variant Exon 23 of 24 5 ENSP00000355123.2 H0YIS1
COL11A2ENST00000477772.1 linkn.272+3506C>T intron_variant Intron 5 of 8 2

Frequencies

GnomAD3 genomes
AF:
0.101
AC:
15312
AN:
151370
Hom.:
1012
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.0275
Gnomad AMI
AF:
0.0505
Gnomad AMR
AF:
0.0720
Gnomad ASJ
AF:
0.0795
Gnomad EAS
AF:
0.108
Gnomad SAS
AF:
0.184
Gnomad FIN
AF:
0.179
Gnomad MID
AF:
0.0573
Gnomad NFE
AF:
0.137
Gnomad OTH
AF:
0.0819
GnomAD2 exomes
AF:
0.122
AC:
29605
AN:
243556
AF XY:
0.127
show subpopulations
Gnomad AFR exome
AF:
0.0247
Gnomad AMR exome
AF:
0.0594
Gnomad ASJ exome
AF:
0.0889
Gnomad EAS exome
AF:
0.0966
Gnomad FIN exome
AF:
0.179
Gnomad NFE exome
AF:
0.134
Gnomad OTH exome
AF:
0.123
GnomAD4 exome
AF:
0.134
AC:
195391
AN:
1460200
Hom.:
13931
Cov.:
41
AF XY:
0.135
AC XY:
98184
AN XY:
726324
show subpopulations
African (AFR)
AF:
0.0239
AC:
800
AN:
33454
American (AMR)
AF:
0.0600
AC:
2680
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.0907
AC:
2370
AN:
26120
East Asian (EAS)
AF:
0.112
AC:
4437
AN:
39676
South Asian (SAS)
AF:
0.184
AC:
15828
AN:
86224
European-Finnish (FIN)
AF:
0.178
AC:
9334
AN:
52426
Middle Eastern (MID)
AF:
0.106
AC:
609
AN:
5760
European-Non Finnish (NFE)
AF:
0.137
AC:
151869
AN:
1111504
Other (OTH)
AF:
0.124
AC:
7464
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.527
Heterozygous variant carriers
0
9742
19485
29227
38970
48712
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5506
11012
16518
22024
27530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.101
AC:
15309
AN:
151486
Hom.:
1012
Cov.:
27
AF XY:
0.103
AC XY:
7638
AN XY:
73992
show subpopulations
African (AFR)
AF:
0.0275
AC:
1135
AN:
41302
American (AMR)
AF:
0.0720
AC:
1096
AN:
15226
Ashkenazi Jewish (ASJ)
AF:
0.0795
AC:
276
AN:
3470
East Asian (EAS)
AF:
0.108
AC:
551
AN:
5096
South Asian (SAS)
AF:
0.182
AC:
869
AN:
4762
European-Finnish (FIN)
AF:
0.179
AC:
1880
AN:
10516
Middle Eastern (MID)
AF:
0.0548
AC:
16
AN:
292
European-Non Finnish (NFE)
AF:
0.137
AC:
9266
AN:
67814
Other (OTH)
AF:
0.0829
AC:
174
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
699
1398
2098
2797
3496
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.121
Hom.:
4787
Bravo
AF:
0.0870
TwinsUK
AF:
0.140
AC:
518
ALSPAC
AF:
0.138
AC:
532
ESP6500AA
AF:
0.0273
AC:
120
ESP6500EA
AF:
0.131
AC:
1130
ExAC
AF:
0.122
AC:
14660
Asia WGS
AF:
0.117
AC:
405
AN:
3478
EpiCase
AF:
0.127
EpiControl
AF:
0.120

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Pro894Leu in Exon 36 of COL11A2: This variant is not expected to have clinical s ignificance because it has been identified in 13.1% (919/7012) of European Ameri can chromosomes from a broad population by the NHLBI Exome Sequencing Project (h ttp://evs.gs.washington.edu/EVS; dbSNP rs2855430). -

Oct 03, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 04, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Otospondylomegaepiphyseal dysplasia, autosomal dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Otospondylomegaepiphyseal dysplasia, autosomal recessive Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fibrochondrogenesis 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Stickler Syndrome, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.48
CADD
Pathogenic
33
DANN
Uncertain
1.0
DEOGEN2
Benign
0.087
T;T;.
Eigen
Pathogenic
1.1
Eigen_PC
Pathogenic
0.88
FATHMM_MKL
Pathogenic
0.98
D
MetaRNN
Benign
0.0039
T;T;T
MetaSVM
Benign
-0.81
T
PhyloP100
9.8
PrimateAI
Uncertain
0.77
T
PROVEAN
Pathogenic
-6.8
D;D;D
REVEL
Benign
0.28
Sift
Benign
0.089
T;T;T
Sift4G
Uncertain
0.018
D;D;D
Vest4
0.36
MPC
0.99
ClinPred
0.029
T
GERP RS
4.0
gMVP
0.31
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.92
dbscSNV1_RF
Pathogenic
0.85
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2855430; hg19: chr6-33141280; COSMIC: COSV59503315; COSMIC: COSV59503315; API